News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

InVivo Therapeutics Corporation (NVIV) Appoints Christopher McNulty As Vice President, Business Development & Investor Relations



7/1/2014 12:01:57 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

InVivo Therapeutics Holdings Corp. (NVIV) today announced that the role of Christopher McNulty has been expanded to include investor relations and corporate communications. Mr. McNulty has been serving as Vice President, Business Development, and will continue to lead efforts in that area.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES